Tag: OOS

Addressing Foil Tearing Issues During Cartoning: A CAPA Breakdown Foil tearing during the cartoning process can significantly disrupt production and lead to compliance issues in pharmaceutical manufacturing. Such defects not…

Understanding and Resolving Foil Tearing Issues Post Artwork Change The pharmaceutical manufacturing process is intricate and susceptible to various disturbances that can impact product integrity. One prevalent issue is the…

Addressing Blister Sealing Failures Post-Artwork Change: A Comprehensive Recall Risk Analysis In pharmaceutical manufacturing, changes in production, especially in artwork or labeling, often have unforeseen implications, such as blister sealing…

“`html Analyzing and Resolving Foil Tearing Issues During Inspection to Mitigate Recall Risks In the pharmaceutical manufacturing landscape, the integrity of packaging is paramount. One recurring failure signal is the…

Addressing Incorrect Blister Count in Distribution: Root Cause Analysis for Pharma Professionals In the highly regulated pharmaceutical manufacturing environment, an incorrect blister count during distribution preparation can lead to significant…

Root Cause Analysis for Incorrect Blister Count During Cartoning In the pharmaceutical manufacturing sector, accurate blister counts during cartoning are critical for ensuring compliance and product integrity. Occurrences of incorrect…

Understanding and Addressing Carton Misfeed Issues During Distribution Preparation In pharmaceutical manufacturing, carton misfeeding during distribution preparation can significantly disrupt the production line, resulting in extended downtimes, resource wastage, and…

Analyzing Foil Tearing Issues After Artwork Changes: A Comprehensive Approach In pharmaceutical packaging, artwork changes on foil can lead to unforeseen complications, particularly foil tearing during the manufacturing process. Such…

CAPA Breakdown for Blister Count Discrepancies After Artwork Update In pharmaceutical manufacturing, precision is paramount, particularly in the production and packaging of dosage forms such as blisters. An occurrence of…

Managing Risks Associated with Incorrect Blister Count during Distribution Preparation The pharmaceutical industry is no stranger to challenges in manufacturing and quality control, particularly concerning machine operation. One recurrent issue…

Understanding and Resolving Vision System Rejections During Inspection In a pharmaceutical manufacturing setting, maintaining product quality is paramount. A recurring issue faced by production teams is vision system rejection during…

Understanding and Addressing Blister Sealing Failures in Packaging Equipment Failures in blister sealing during blister packing can significantly disrupt pharmaceutical manufacturing processes. Such incidents not only lead to production delays…